Principal Scientist, External Innovation/ China Onolocy and Hematology Lead at Bristol-Myers Squibb

Shanghai, China

Bristol-Myers Squibb Logo
Not SpecifiedCompensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

  • Deep scientific expertise in oncology and hematology
  • Ability to assess strategic R&D opportunities aligning with BMS's mission
  • Experience at the interface between Research, Development, Business Development, Global Alliance Management, and external collaborators
  • Based in Shanghai, reporting to the Head of China Integrative Sciences

Responsibilities

  • Drive assessments of external innovation opportunities in China, focusing on new technologies, therapeutic targets, preclinical assets, and research programs in oncology and hematology
  • Conduct rigorous evaluation of research hypotheses, study designs, data quality, and results interpretation, providing critical input to internal decision-making processes
  • Leverage expertise in oncology and hematology to evaluate strategies and address gaps in BMS’s areas of scientific interest
  • Collaborate with internal R&D teams and business development colleagues to define the scope and structure of external research proposals
  • Coordinate the generation of research proposals for partnerships and assist in the development of collaboration agreements
  • Align external innovation programs with internal R&D priorities to extend and complement BMS's pipeline in oncology and hematology
  • Identify and assess preclinical assets or molecules in development with potential to deliver transformative patient outcomes
  • Partner with internal stakeholders and external groups to facilitate seamless communication regarding project strategies, study designs, and progress updates
  • Contribute to the implementation of the external innovation pillar of BMS’s China 2030 strategy
  • Proactively seek and evaluate scientific collaborations with academic, biotech, and industry leaders in China, including innovative preclinical assets, early-stage programs, or novel therapeutic targets that align with BMS R&D goals
  • Prepare detailed progress reports and presentations to summarize key activities and outcomes of external collaborations, ensuring alignment with senior management’s expectations

Skills

Oncology
Hematology
Business Development
Alliance Management
Preclinical Research
Strategic Partnerships
R&D Evaluation
External Innovation

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters
1887Year Founded
$33,706.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Benefits

Flexible Work Hours
Hybrid Work Options
Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.
BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.
Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.
The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.
BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.
The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.
BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI